Table 3 Ratio of KIR2DL1- to... | American Society of Hematology

Table 3

Ratio of KIR2DL1- to KIR2DL2/3-expressing NK cells

KIR Haplotype group	HLA-C ligand	Ratio KIR2DL1/KIR2DL2/3 (single/single KIR)*	P†
Group A	C1/C1	0.69 (0.55)	< .001 (< .001)
	C1/C2	0.87 (1.04)
	C2/C2	1.51 (4.39)
Group B	C1/C1	0.40 (0.28)	.330 (.356)
	C1/C2	0.67 (0.81)
	C2/C2	0.58 (0.59)
Group B KIR2DL2⁺	C1/C1	0.40 (0.27)	.748 (.660)
	C1/C2	0.62 (0.80)
	C2/C2	0.42 (0.36)
Group B KIR2DL2⁻	C1/C1	0.61 (0.49)	.011 (.005)
	C1/C2	0.84 (0.84)
	C2/C2	1.42 (1.79)

KIR Haplotype group	HLA-C ligand	Ratio KIR2DL1/KIR2DL2/3 (single/single KIR)*	P†
Group A	C1/C1	0.69 (0.55)	< .001 (< .001)
	C1/C2	0.87 (1.04)
	C2/C2	1.51 (4.39)
Group B	C1/C1	0.40 (0.28)	.330 (.356)
	C1/C2	0.67 (0.81)
	C2/C2	0.58 (0.59)
Group B KIR2DL2⁺	C1/C1	0.40 (0.27)	.748 (.660)
	C1/C2	0.62 (0.80)
	C2/C2	0.42 (0.36)
Group B KIR2DL2⁻	C1/C1	0.61 (0.49)	.011 (.005)
	C1/C2	0.84 (0.84)
	C2/C2	1.42 (1.79)

Expression frequency of KIR2DL1 divided by expression frequency of KIR2DL2/3. Parentheses are ratio of single-KIR2DL1⁺/single-KIR2DL2/3.

P values were calculated by ANOVA. Values for P less than .05 are significant.